Pretreatment glucose status determines HCC development in HCV patients with mild liver disease after curative antiviral therapy

Although diabetes mellitus (DM) is known to increase the risk of hepatitis C virus (HCV)-related hepatocellular carcinoma (HCC), the impact of dynamic glucose status on HCC occurrence in chronic hepatitis C (CHC) patients receiving antiviral therapy is unclear. In total, 1112 biopsy-proven patients...

Descripción completa

Detalles Bibliográficos
Autores principales: Huang, Chung-Feng, Yeh, Ming-Lun, Huang, Cing-Yi, Tsai, Pei-Chien, Ko, Yu-Min, Chen, Kuan-Yu, Lin, Zu-Yau, Chen, Shinn-Cherng, Dai, Chia-Yen, Chuang, Wan-Long, Huang, Jee-Fu, Yu, Ming-Lung
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2016
Materias:
4500
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5058864/
https://www.ncbi.nlm.nih.gov/pubmed/27399135
http://dx.doi.org/10.1097/MD.0000000000004157

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5058864/
https://www.ncbi.nlm.nih.gov/pubmed/27399135
http://dx.doi.org/10.1097/MD.0000000000004157

Ejemplares similares